[HTML][HTML] Sick sinus syndrome: a review

M Semelka, J Gera, S Usman - American family physician, 2013 - aafp.org
Sick sinus syndrome refers to a collection of disorders marked by the heart's inability to
perform its pacemaking function. Predominantly affecting older adults, sick sinus syndrome …

Towards an understanding of complex protein networks

CL Tucker, JF Gera, P Uetz - Trends in cell biology, 2001 - cell.com
Large-scale two-hybrid screens have generated a wealth of information describing potential
protein–protein interactions. When compiled with data from systematic localizations of …

[HTML][HTML] AKT activity determines sensitivity to mammalian target of rapamycin (mTOR) inhibitors by regulating cyclin D1 and c-myc expression

JF Gera, IK Mellinghoff, Y Shi, MB Rettig, C Tran… - Journal of Biological …, 2004 - ASBMB
Prior work demonstrates that AKT activity regulates sensitivity of cells to G 1 arrest induced
by mammalian target of rapamycin (mTOR) inhibitors such as rapamycin and CCI-779. To …

mTORC2 activity is elevated in gliomas and promotes growth and cell motility via overexpression of rictor

…, J Martin, OD Jo, R Vartanian, A Funk, J Gera - Cancer research, 2007 - AACR
… This article is dedicated to the memory of Sandor Gera who succumbed to glioblastoma
multiforme on October 17, 2006. … J Biol Chem … J Biol Chem …

Mammalian target of rapamycin inhibitors activate the AKT kinase in multiple myeloma cells by up-regulating the insulin-like growth factor receptor/insulin receptor …

Y Shi, H Yan, P Frost, J Gera, A Lichtenstein - Molecular cancer therapeutics, 2005 - AACR
Mammalian target of rapamycin (mTOR) inhibitors, such as rapamycin and CCI-779, have
shown preclinical potential as therapy for multiple myeloma. By inhibiting expression of cell …

Oncogenic EGFR signaling activates an mTORC2–NF-κB pathway that promotes chemotherapy resistance

…, A Rinkenbaugh, WH Yong, HV Vinters, JF Gera… - Cancer discovery, 2011 - AACR
Although it is known that mTOR complex 2 (mTORC2) functions upstream of Akt, the role of
this protein kinase complex in cancer is not well understood. Through an integrated analysis …

Enhanced Sensitivity of Multiple Myeloma Cells Containing PTEN Mutations to CCI-779

Y Shi, J Gera, L Hu, J Hsu, R Bookstein, W Li… - Cancer research, 2002 - AACR
Recent work identifies the AKT kinase as a potential mediator of tumor expansionin multiple
myeloma. The finding of PTEN mutations in several myeloma cell lines suggests that loss of …

The role of lipids and membranes in the pathogenesis of Alzheimer's disease: a comprehensive view

B Penke, G Paragi, J Gera, R Berkecz… - Current Alzheimer …, 2018 - ingentaconnect.com
… Hardy J. Membrane damage is at the core of Alzheimer's disease. Lancet Neurol 16(5):
342-… [100] Di Scala C, Yahi N, Lelievre C, Garmy N, Chahinian H, Fantini J. Biochemical …

Synthetic single domain antibodies for the conformational trapping of membrane proteins

…, MN Hug, S Huber, M Siegrist, L Hetemann, J Gera… - elife, 2018 - elifesciences.org
10.7554/eLife.34317.001 Mechanistic and structural studies of membrane proteins require
their stabilization in specific conformations. Single domain antibodies are potent reagents for …

In vivo antitumor effects of the mTOR inhibitor CCI-779 against human multiple myeloma cells in a xenograft model

…, B Hoang, Y Shi, J Gera, H Yan, P Frost, J Gibbons… - Blood, 2004 - ashpublications.org
In vitro studies indicate the therapeutic potential of mTOR inhibitors in treating multiple
myeloma. To provide further support for this potential, we used the rapamycin analog CCI-779 in …